Company / CapEx per Share
TherapeuticsMD, Inc. CapEx per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2022
5-year range
$0.00 / $0.01
FY2018-FY2022
Trend
-51.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2016 to $0.01 in FY2021.
Based on SEC 10-K filings.
0.00 in FY2022 with a 5-year CAGR of +36.3%.
Improved from $0.00 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +148.7%
- 5-Year CAGR
- +36.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, capex per share decreased 51.6% year-over-year.
- Peak capex per share was recorded in FY2021.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.00 | -51.6% |
| FY2021 | $0.01 | +921.2% |
| FY2020 | $0.00 | +211.3% |
| FY2019 | $0.00 | -86.0% |
| FY2018 | $0.00 | +117.9% |
| FY2017 | $0.00 | +382.8% |
| FY2016 | $0.00 | -38.2% |
| FY2015 | $0.00 | -38.6% |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026